SCHEMBL18365336

SCHEMBL18365336

CN(C)c1ccc2c(c1)OC1=CC(C)(N(C)C)C=CC1=C2c1ccc(C(=O)ON2C(=O)CCC2=O)cc1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14597208 0.83 — —
SCHEMBL14627858 0.83 — —
SCHEMBL18882644 0.81 — —
SCHEMBL16491631 0.80 USP2 (0.34) —
SCHEMBL18365334 0.78 P2RY6 (0.39) —
SCHEMBL18677237 0.76 F7 (0.31) —
SCHEMBL14452143 0.75 POLB (0.33) —
SCHEMBL14470094 0.75 POLB (0.33) —
SCHEMBL19275375 0.74 HDAC1 (0.35) —
SCHEMBL16518794 0.74 TSHR (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170087258-A1 TCO CONJUGATES AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK 2017-03-30 — — US disclosed
EP-2623609-B1 Labeling and detection of post translationally modified proteins LIFE TECHNOLOGIES CORP (US) 2017-01-04 — — EP disclosed
Send feedback